Double victory for Novartis at Federal Circuit

10-12-2018

Double victory for Novartis at Federal Circuit

tumsasedgars / iStockphoto.com

The US Court of Appeals for the Federal Circuit has reversed one decision and affirmed another in two cases involving Novartis, with both judgments delivering victory to the Swiss pharmaceutical company.


US Court of Appeals for the Federal Circuit, Novartis, patent infringement, obviousness-type double patenting, everolimus, fingolimod, patent invalidation

LSIPR